Brookstone Capital Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.32M | Buy |
|
|||||
|
2025
Q2 | $1.52M | Buy |
|
|||||
|
2025
Q1 | $985K | Sell |
|
|||||
|
2024
Q4 | $1.27M | Sell |
|
|||||
|
2024
Q3 | $1.95M | Sell |
|
|||||
|
2024
Q2 | $2.25M | Buy |
|
|||||
|
2024
Q1 | $2.06M | Sell |
|
|||||
|
2023
Q4 | $2.74M | Buy |
|
|||||
|
2023
Q3 | $1.4M | Sell |
|
|||||
|
2023
Q2 | $1.18M | Sell |
|
|||||
|
2023
Q1 | $1.33M | Sell |
|
|||||
|
2022
Q4 | $1.15M | Buy |
|
|||||
|
2022
Q3 | $814K | Sell |
|
|||||
|
2022
Q2 | $1.72M | Buy |
|
|||||
|
2022
Q1 | $878K | Sell |
|
|||||
|
2021
Q4 | $765K | Sell |
|
|||||
|
2021
Q3 | $787K | Sell |
|
|||||
|
2021
Q2 | $692K | Sell |
|
|||||
|
2021
Q1 | $546K | Buy |
|
|||||
|
2020
Q4 | $552K | Buy |
|
|||||
|
2020
Q3 | $538K | Sell |
|
|||||
|
2020
Q2 | $525K | Sell |
|
|||||
|
2020
Q1 | $673K | Sell |
|
|||||
|
2019
Q4 | $664K | Sell |
|
|||||
|
2019
Q3 | $595K | Buy |
|
|||||
|
2019
Q2 | $553K | Buy |
|
|||||
|
2019
Q1 | $444K | Buy |
|
|||||
|
2018
Q4 | $333K | Buy |
|
|||||
|
2018
Q3 | $315K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $291K | Buy |
|